About this trial
Chronic Obstructive Pulmonary Disease is a particular type of irreversible disease that may damage or obstruct airways and make it difficult to breath. This respiratiry condition may lead to shallow breathing.
Breathing exercisers help to manage hyperventilation often seen in COPD patients. To handle respiratory complications patients are advised to practice breathing techniques along with pharmacological management
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 40-64 years
Both genders (male and female)
Grade 1-3 on mMRC scale of dyspnea
COPD mild stage according to global initiative for chronic obstructive lung disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted
Disqualifiers
Moderate, severe and very severe stage of COPD according to GOLD classification
Patients having acute exerbation of COPD
Patients diagnosed with acute infection
Patients unable to follow command and instructions
Trial design
Parallel
Treatments tested in this trial
Pilates Breathing Technique along with standard pharmacological management
Procedure/SurgeryPatients in this group will receive pilates breathing technique along with pharmacological management. A total 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Pilates breathing will be performed in sitting or supine position. The patient will place a hand over the Lower Posterior rib Cage and inhale through the nose. While breathing they will actively contract the Transverse Abdominis (TrA) as if preparing for punch or holding in urine and engaging the pelvic floor muscles.
Pursed-lip breathing along with pharmacological management
Procedure/SurgeryPatient in this group will receive pursed-lip breathing along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days at home. The patient will sit comfortably with straight back and relaxed shoulders. They will inhale slowly through the nose, with a deep relaxed breath, and then exhale slowly through the pursed lips, as if blowing out a candle. The exhalation should take 2-3 times longer than inhalation. This breathing cycle will be repeated with a focus on slow and relaxed breathing. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist
Treatment groups
Trial outcomes
Primary outcomes
Chest Expansion
Evaluation will be done using inch tape (inches) for Chest Expansion
Peak expiratory flow rate
Evaluation will be done by using Peak flow meter
Dyspnea
Evaluation will be done by using Modified Medical Research Council Dyspnea Scale (mMRC)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.